Core Viewpoint - The court ruled to dismiss the lawsuit filed by Cytiva Sweden AB against Jiangsu Hanbang Technology Co., Ltd., stating that the patent in question was declared invalid by the National Intellectual Property Administration [2][4]. Case Background - Cytiva Sweden AB claimed that Hanbang Technology's STK series automatic homogenizers infringed its patent for a "separation medium homogenizer" in China, seeking to stop production and sales, and demanding compensation of 5 million RMB for economic losses and 1 million RMB for other reasonable expenses [2][3]. - The lawsuit was initiated in September 2024, and the company responded by filing a request for invalidation of the patent with the National Intellectual Property Administration [3]. Latest Developments - The Shanghai Intellectual Property Court issued a civil ruling stating that the patent held by Cytiva Sweden AB was declared entirely invalid by the National Intellectual Property Administration, leading to the dismissal of the lawsuit [4][6]. - The total amount involved in the case was 6 million RMB [5]. Impact on the Company - The court's ruling will not negatively impact the company's daily operations or its current and future financial performance [2][6]. - The company will continue to monitor the case and fulfill its information disclosure obligations to protect the rights of the company and its shareholders [6].

证券代码：688755 证券简称：汉邦科技 公告编号：2025-033 案件所处的诉讼阶段：裁定驳回原告起诉。 公司所处的当事人地位：被告。 涉案金额：人民币 600 万元。 江苏汉邦科技股份有限公司 关于诉讼进展的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 是否会对公司损益产生负面影响：本次法院裁定驳回原告起诉，不会对 公司的日常生产经营产生负面影响，也不会对公司当期及未来的损益产生负面影 响。 江苏汉邦科技股份有限公司（以下简称"公司"或"汉邦科技"）于近日收 到上海知识产权法院出具的《民事裁定书》（（2024）沪 73 知民初 227 号）， 上海知识产权法院裁定驳回原告思拓凡瑞典有限公司（Cytiva Sweden AB）的起 诉。现将有关情况公告如下： 一、案涉诉讼的基本情况 2024 年 9 月，原告思拓凡瑞典有限公司诉称公司的自动匀浆罐（STK 系列自 动匀浆罐）产品侵犯了其在中国申请的名称为"分离介质浆料罐"的发明专利， 并发现上海耐利流体设备有限公司（以下简称"上海耐利"）共同参 ...

Core Points - The company announced a cash dividend of 0.1 yuan per share (including tax) [1][2] - The profit distribution plan was approved at the company's second extraordinary general meeting of shareholders on September 11, 2025 [1] Distribution Plan - The distribution is based on a total share capital of 88,000,000 shares, resulting in a total cash dividend payout of 8,800,000 yuan (including tax) [2] - The distribution is for the first half of 2025 [1] Implementation Details - The dividends will be distributed through China Securities Depository and Clearing Corporation Limited Shanghai Branch to shareholders registered by the end of the trading day on the record date [3] - Shareholders who have completed designated transactions can receive their cash dividends on the payment date at their designated securities business department [3] Taxation Information - For individual shareholders and securities investment funds, dividends are subject to different tax treatments based on the holding period [5][6] - For shares held for more than one year, dividends are exempt from individual income tax, resulting in an actual cash dividend of 0.1 yuan per share [5] - For qualified foreign institutional investors (QFII), a 10% withholding tax applies, leading to a net cash dividend of 0.09 yuan per share [6][7] Contact Information - For inquiries regarding the distribution of rights, shareholders can contact the board office at 0517-83706908 [8]

Core Insights - Hanbang Technology's stock decreased by 0.83% on September 22, with a trading volume of 22.01 million yuan [1] - The company reported a net financing purchase of 1.136 million yuan on the same day, with a total financing balance of 92.68 million yuan, accounting for 12.27% of its market capitalization [1] Financing Overview - On September 22, Hanbang Technology had a financing buy amount of 4.101 million yuan and a financing repayment of 2.965 million yuan [1] - The company had no short selling activity on the same day, with a short selling balance of 0 yuan [1] Company Profile - Hanbang Technology, established on October 28, 1998, is located in Huai'an Economic and Technological Development Zone, Jiangsu Province [1] - The company specializes in providing separation and purification equipment, consumables, application technology services, and related technical solutions for the pharmaceutical and life sciences sectors [1] - The revenue composition includes 70.99% from small molecule drug separation and purification equipment, 22.94% from large molecule drug separation and purification equipment, and 6.07% from other sources [1] Financial Performance - As of June 30, 2025, Hanbang Technology reported a revenue of 349 million yuan, a year-on-year increase of 5.99%, while the net profit attributable to shareholders decreased by 26.24% to 27.7976 million yuan [2] - The number of shareholders decreased by 48.43% to 9,372, while the average circulating shares per person increased by 93.92% to 1,764 shares [2] Shareholder Information - As of June 30, 2025, the largest circulating shareholder is Dongfanghong Medical Upgrade Stock Initiation A (015052), holding 483,700 shares as a new shareholder [2]

Group 1 - The company announced a profit distribution plan for the first half of 2025, proposing a cash dividend of 0.1 yuan per share (tax included) [2] - The record date for the dividend is set for September 26, 2025, with the ex-dividend date and payment date both on September 29, 2025 [2]

Market Performance - The new stock index fell by 0.62% in the third week of September, marking three consecutive weeks of decline[7] - The Shanghai Composite Index dropped by 1.30% during the same period, with significant pullbacks in major financial sectors like banks and insurance[7] - Over 60% of the components in the new stock index experienced declines in the same week[7] Trading Activity - Trading activity in the new stock market increased, with turnover rates for the new stock index and near-term new stock index rising by 2.67 percentage points and 3.94 percentage points, respectively[17] - The trading volume for the new stock index and near-term new stock index increased by 172 million shares and 138 million shares, respectively, compared to the previous week[20] - The net active selling in the new stock sector was 2.866 billion yuan, a decrease of 1.216 billion yuan from the previous week[22] Upcoming Unlocks - In the fourth week of September, 8 new stocks are expected to unlock, with a total market value of approximately 188.59 billion yuan[34] - The largest unlock will be for Hehe Information, with a market value of 10.835 billion yuan, contributing significantly to the overall unlock scale[34] Investor Returns - From January to September 2025, A/B class investors achieved average returns of 6.7555 million yuan and 6.1804 million yuan per account, with the Shanghai market leading in returns[38] - The average price-to-earnings (P/E) ratio for the new stock index was 62.3X, while the near-term new stock index was at 39.6X, indicating valuation disparities[14]

2025年半年度权益分派实施公告 江苏汉邦科技股份有限公司 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 证券代码：688755 证券简称：汉邦科技 公告编号：2025-032 重要内容提示： 每股现金红利0.1元（含税） 相关日期 | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/9/26 | 2025/9/29 | 2025/9/29 | 一、 通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 9 月 11 日的2025年第二次临时股东会审议通 过。 二、 分配方案 1. 发放年度：2025年半年度 2. 分派对象： | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/9/26 | 2025/9/29 | 2025/9/29 | 四、 分配实施办法 1. 实施办法 （1）无限售条件流通股的红利委托中国结算上海分公司通过其资金清算系统 向股权登记日上海证券交易所收市后登记在册并在上海 ...

Core Insights - On September 18, Hanbang Technology experienced a decline of 1.69% with a trading volume of 53.52 million yuan [1] - The company had a net financing buy of -0.94 million yuan on the same day, with a total financing and securities balance of 92.89 million yuan [1] Financing Overview - On September 18, Hanbang Technology had a financing buy of 10.95 million yuan, with a current financing balance of 92.89 million yuan, accounting for 12.21% of the circulating market value [1] - There were no shares repaid or sold in the securities lending market on that day, resulting in a securities lending balance of 0.00 yuan [1] Company Profile - Hanbang Technology, established on October 28, 1998, is located in Huai'an Economic and Technological Development Zone, Jiangsu Province [1] - The company specializes in providing separation and purification equipment, consumables, application technology services, and related technical solutions for the pharmaceutical and life sciences sectors [1] - The revenue composition includes: 70.99% from small molecule drug separation and purification equipment, 22.94% from large molecule drug separation and purification equipment, and 6.07% from other sources [1] Financial Performance - As of June 30, the number of shareholders for Hanbang Technology was 9,372, a decrease of 48.43% from the previous period [2] - The average circulating shares per person increased by 93.92% to 1,764 shares [2] - For the first half of 2025, the company reported a revenue of 349 million yuan, a year-on-year increase of 5.99%, while the net profit attributable to the parent company was 27.80 million yuan, a decrease of 26.24% year-on-year [2] - As of June 30, the largest circulating shareholder was Dongfanghong Medical Upgrade Stock Initiation A (015052), holding 483,700 shares as a new shareholder [2]

Core Insights - Hanbang Technology's stock price increased by 0.04% on September 17, with a trading volume of 29.5371 million yuan [1] - The company experienced a net financing outflow of 2.5878 million yuan on the same day, with a total financing and securities balance of 93.8258 million yuan [1] - As of June 30, 2025, Hanbang Technology reported a revenue of 349 million yuan, a year-on-year increase of 5.99%, while net profit decreased by 26.24% to 27.7976 million yuan [2] Financing and Trading Data - On September 17, Hanbang Technology had a financing buy amount of 2.8171 million yuan and a financing repayment of 5.4048 million yuan, resulting in a net financing buy of -2.5878 million yuan [1] - The current financing balance of 93.8258 million yuan accounts for 12.12% of the company's market capitalization [1] - No shares were sold or repaid in the securities lending market on September 17, with a total securities lending balance of 0 [1] Shareholder Information - As of June 30, 2025, the number of shareholders for Hanbang Technology was 9,372, a decrease of 48.43% from the previous period [2] - The average number of circulating shares per shareholder increased by 93.92% to 1,764 shares [2] - The largest circulating shareholder is Dongfanghong Medical Upgrade Stock Initiation A (015052), holding 483,700 shares as a new shareholder [2] Business Overview - Hanbang Technology, established on October 28, 1998, specializes in providing separation and purification equipment, consumables, application technology services, and related technical solutions for the pharmaceutical and life sciences sectors [1] - The revenue composition of the company includes 70.99% from small molecule drug separation and purification equipment, 22.94% from large molecule drug separation and purification equipment, and 6.07% from other sources [1]

Market Performance - The new stock index decreased by 1.13% during the second week of September 2025, while the overall market showed signs of recovery[7] - The semiconductor sector led the market rebound with a weekly increase of 5.48%[7] - The divergence in the new stock sector was evident, with 60% of the index components declining during the week[7] Trading Activity - Trading activity in the new stock sector continued to decline, with turnover rates for the new stock index and near-term new stock index dropping by 1.80 percentage points and 1.50 percentage points, respectively[19] - The net active selling in the new stock sector amounted to 3.175 billion yuan, a decrease of 288 million yuan from the previous week[24] - The financing and securities lending balance in the new stock sector decreased by 277 million yuan week-on-week[25] New Stock Performance - The average first-day increase for the newly listed stock, Aifenda, was 191.98%, maintaining a high level despite a slight decrease from previous weeks[36] - Aifenda contributed to significant returns for A/B class investors, with individual account gains of 64,300 yuan and 60,900 yuan, respectively[40] Upcoming Unlocks - In the third week of September, only two new stocks are expected to unlock, with a total unlock value of 205 million yuan, continuing the downward trend[34]